Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKonya Beyhekim Training and Research Hospital
About this trial
This study aims to better understand different types of low back pain in patients with ankylosing spondylitis. Low back pain is a common problem in these patients and may affect daily activities and quality of life.
A total of 200 patients with ankylosing spondylitis who have had low back pain for at least three months will be included in the study. Participants will be evaluated during a single visit.
The study will assess pain severity, physical function, and quality of life using standard questionnaires. It will also examine how different pain types are related to these outcomes.
The results of this study may help improve the understanding of pain in ankylosing spondylitis and support better patient management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being over 18 years of age Voluntary participation in the study Having been diagnosed with ankylosing spondylitis
Disqualifiers
Those under 18 years of age
Those with major psychiatric illnesses
Those with communication problems
Other causes of back pain
Trial population
200 patients with Ankylosing Spondylitis who applied to the physical therapy and rehabilitation clinics of Konya Beyhekim Training and Research Hospital with complaints of lower back pain lasting at least 3 months will be included in the study.
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis (Back Paın)
disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ)
Time frame
Baseline2
Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing
Quality of life will be assessed using the SF-36
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov